Yeast-Based Platforms for Next-Generation Human Health Applications

Clicks: 4
ID: 338025
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #53 of 53 articles by views in fems yeast research

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Yeast platforms are rapidly transitioning from traditional eukaryotic model organisms to versatile, programmable chassis for next-generation human health applications. This review systematically examines the translational evolution of conventional and non-conventional yeasts including Saccharomyces cerevisiae, Komagataella phaffii, Saccharomyces boulardii, and Yarrowia lipolytica and redefines them as scalable biomanufacturing factories and advanced living therapeutics. We highlight milestone advancements in synthetic biology toolkits that lower technical barriers, such as CRISPR-mediated multiplex editing, modular cloning frameworks, and high-throughput secretion screening. We focus on sophisticated glycoengineering strategies for humanized N-glycosylation, alongside data-driven paradigms that leverage artificial intelligence to predict gene expression and streamline strain design. In clinical domains, we detail the established success of yeast in producing subunit or virus-like particle vaccines (e.g. HBV and HPV) and therapeutic enzymes (e.g. ecallantide), alongside its emerging role as gut-adapted live biotherapeutic products (LBPs) engineered for in situ delivery and biosensing. Finally, we explore specialized non-conventional platforms, focusing on lipid- and acetyl-CoA-rich hosts for lipophilic drug discovery, and stress-tolerant systems optimized for economical, feedstock-flexible bioprocesses. In summary, this review underscores the integrated value of yeast systems across disease modeling, industrial manufacturing, and clinical intervention, charting future directions to address global health challenges.
Reference Key
openalex_W7224763957 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Sangdo Yook, Jae Won Lee, Myungseo Park, Hyun Gi Koh, Jonghyeok Shin
Are you one of these authors? Claim your profile
Journal fems yeast research
Year 2026
DOI
10.1093/femsyr/foag058
URL
https://academic.oup.com/femsyr/advance-article-pdf/doi/10.1093/femsyr/foag058/72616536/foag058.pdf
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.